In addition to transcriptionally controlled AF exons, common events consisted mainly of SE that presented preferential inclusion in RPE in the control contrast (MRPS31, MTX1, SHLD2P3, and HNRNPDL), while the exon becomes excluded in RPE in the patient contrast. The gene discussed is MRPS31; the disease is atrial fibrillation.